Triphenyltetrazolium bromide Inhibitor

Triphenyltetrazolium bromide may be used to detect experimental cerebral infarction and biochemical analysis.

Kakimoto Y, Tsuruyama T, Miyao M, Abiru H, Sumiyoshi S, Kotani H, Haga H, Tamaki K. The effectiveness and limitations of triphenyltetrazolium chloride to detect acute myocardial infarction at forensic autopsy. Am J Forensic Med Pathol. 2013 Sep;34(3):242-7. doi: 10.1097/PAF.0b013e31828879cd. PubMed PMID: 23949140.
Sun YY, Yang D, Kuan CY. Mannitol-facilitated perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) for detection of experimental cerebral infarction and biochemical analysis. J Neurosci Methods. 2012 Jan 15;203(1):122-9. doi: 10.1016/j.jneumeth.2011.09.029. Epub 2011 Oct 1. PubMed PMID: 21982741; PubMed Central PMCID: PMC3268057.

Small volumes of Triphenyltetrazolium bromide, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5756661 is an inhibitor targeting Triphenyltetrazolium bromide.